Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1265P is a pseudogene derived from the U6 small nuclear RNA (snRNA) family. The functional U6 snRNA is a critical non-coding RNA component of the spliceosome, which catalyzes the removal of introns from pre-messenger RNA (pre-mRNA) during the RNA splicing process. However, pseudogenes such as RNU6-1265P are genetic elements that arise by retrotransposition or genomic duplication events, leading to non-functional copies that do not contribute to spliceosome assembly or function. These U6 snRNA pseudogenes are widely present in vertebrate genomes and have no known biological or therapeutic function, serving instead as molecular fossils or markers of retrotransposon activity. They are not considered drug targets, nor do they have clinical, biomarker, or disease association roles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1265, pseudogene (RNU6-1265P).